Guangzhou Chenyue Technology Co., Ltd – Trademark Portfolio
Entity Type: 16
Guangzhou Chenyue Technology Co., Ltd has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as FACRAFT and TWICETWO. Filings span 3 Nice Classification classes, with the highest activity in Class 8 (Hand Tools) and Class 10 (Medical Apparatus). This trademark owner is based in Guangzhou.
D3898, Room 203, 2nd Floor, No.4 Yuejia Second Street, Shimen Street, Baiyun District
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Chenyue Technology Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Guangzhou Chenyue Technology Co., Ltd have?
Guangzhou Chenyue Technology Co., Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Guangzhou Chenyue Technology Co., Ltd file in?
Guangzhou Chenyue Technology Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.
What are Guangzhou Chenyue Technology Co., Ltd's most well-known trademarks?
Guangzhou Chenyue Technology Co., Ltd's registered trademark portfolio includes well-known marks such as FACRAFT and TWICETWO. These are among 2 currently registered trademarks in the portfolio.
What is Guangzhou Chenyue Technology Co., Ltd's trademark registration success rate?
Guangzhou Chenyue Technology Co., Ltd has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.